Also trades as: 603259.SS (SHH) · $vol 1401M · 2359.HK (HKSE) · $vol 167M · WUXAY (OTC) · $vol 0M

$26.75

+0.00 (+0.00%)

OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 64 · $79.8B mcap · 2.46B float · 0.0000% daily turnover · Short 76% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$39.2B -2.7% ▼

5Y CAGR: +25.0%

Gross Profit

$16.3B -1.8% ▼

5Y CAGR: +26.6%

Operating Income

$11.6B -2.5% ▼

5Y CAGR: +37.7%

Net Income

$9.5B -1.6% ▼

5Y CAGR: +38.5%

EPS (Diluted)

$3.26 +0.6% ▲

5Y CAGR: +37.2%

EBITDA

$14.5B +2.6% ▲

5Y CAGR: +34.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$16.5B	$22.9B	$39.4B	$40.3B	$39.2B
YoY Growth	+28.5%	+38.5%	+71.8%	+2.5%	-2.7%
Cost of Revenue	$10.3B	$14.6B	$24.7B	$23.8B	$23.0B
Gross Profit	$6.3B	$8.3B	$14.7B	$16.6B	$16.3B
Gross Margin	38.0%	36.3%	37.3%	41.1%	41.5%
R&D Expenses	$693M	$942M	$1.6B	$1.4B	$1.2B
SG&A Expenses	$1.1B	$1.5B	$1.7B	$1.1B	$970M
Operating Expenses	$2.9B	$3.7B	$4.9B	$4.7B	$4.7B
Operating Income	$3.4B	$6.0B	$10.7B	$11.9B	$11.6B
Operating Margin	20.5%	26.4%	27.1%	29.4%	29.5%
Interest Expense	$196M	$128M	$160M	$75M	$216M
Income Before Tax	$3.4B	$6.0B	$10.6B	$11.8B	$11.5B
Tax Expense	$383M	$880M	$1.7B	$2.1B	$2.0B
Net Income	$3.0B	$5.1B	$8.8B	$9.6B	$9.5B
Net Margin	17.9%	22.3%	22.4%	23.8%	24.1%
EPS (Diluted)	$1.05	$1.73	$2.82	$3.24	$3.26
EBITDA	$4.5B	$7.4B	$12.4B	$14.2B	$14.5B
Shares Outstanding	2.82B	2.95B	3.13B	2.97B	2.90B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$10.5B	$11.5B	$9.7B	$11.1B	$12.0B	$12.6B	$12.4B	$16.4B
Cost of Revenue	$6.0B	$6.5B	$5.6B	$6.0B	$6.0B	$6.3B	$6.2B	$7.2B
Gross Profit	$4.5B	$5.0B	$4.1B	$5.2B	$6.0B	$6.3B	$6.3B	$9.1B
Gross Margin	42.8%	43.5%	42.3%	46.3%	49.8%	50.3%	50.4%	55.8%
R&D Expenses	$318M	$284M	$224M	$290M	$312M	$294M	$267M	$337M
SG&A Expenses	$2.0B	-$1.4B	$757M	-$368M	$1.1B	-$1.5B	$892M	-$517M
Operating Expenses	$1.7B	$1.3B	-$213M	-$473M	$1.4B	$1.4B	$653M	$1.4B
Operating Income	$2.8B	$3.7B	$4.3B	$5.6B	$4.6B	$5.0B	$5.6B	$7.7B
Operating Margin	26.9%	32.0%	44.5%	50.6%	38.3%	39.6%	45.2%	47.2%
Interest Expense	$43M	$66M	$66M	$81M	$89M	$80M	$31M	$64M
Income Before Tax	$2.8B	$3.7B	$4.3B	$5.6B	$5.1B	$8.9B	$5.6B	$7.9B
Tax Expense	$484M	$719M	$564M	$683M	$1.6B	$1.7B	$937M	$1.5B
Net Income	$2.3B	$2.9B	$3.7B	$4.9B	$3.5B	$7.1B	$4.7B	$6.4B
Net Margin	21.9%	25.3%	38.0%	43.9%	29.2%	56.2%	37.4%	38.9%
EPS (Diluted)	$0.79	$1.01	$1.28	$1.70	$1.21	$2.44	$1.58	$2.17
EBITDA	$3.9B	$4.7B	$4.3B	$5.7B	$5.0B	$8.9B	$5.6B	$7.7B
Shares Outstanding	2.90B	2.90B	2.87B	2.87B	2.86B	2.90B	2.94B	2.92B

WUXIF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet